Accreditation/Credit Designation

Physicians’ Education Resource^®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource^®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Support

This activity is supported by an educational grant from Kyowa Kirin.

Neurology Consultations™: Managing “OFF” Episodes in Parkinson Disease— Keeping Physicians “ON” Top of the Evolving Paradigm

Release Date: June 29, 2021
Expiration Date: June 29, 2022

Activity Overview

This Neurology Consultations^TM activity is a video-based program in which 2 experts use a case-based approach to discuss the treatment and management of off episodes affecting patients with Parkinson disease (PD). In this activity, the faculty focus on current and emerging management strategies. This engaging format is designed to help clinicians identify best practices in the diagnosis and management of PD-related OFF episodes and to improve outcomes for their patients with this disease complication.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Kyowa Kirin.

Instructions for This Activity and Receiving Credit

Complete the activity (including pre- and post-activity assessments).
Answer the evaluation questions.
Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This activity is intended for neurologists. Nurse practitioners, physician assistants, and other health care professionals involved in the management of patients with PD will also be invited to participate in this activity.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

Review the epidemiology, pathogenesis, and pathophysiology of Parkinson disease and associated OFF periods
Discuss the clinical presentation, diagnosis, and symptom burden associated with Parkinson disease OFF periods
Evaluate the efficacy and safety of current and emerging treatments to optimize therapy for Parkinson disease OFF periods

Chairs

Daniel Kremens, MD, JD, FAAN
Associate Professor
Vice Chair of Education
Department of Neurology
Medical Co-Director
Comprehensive Parkinsons Disease and Movement Disorders Center
Sidney Kimmel Medical College at Thomas Jefferson University
Philadelphia, PA

Disclosures: Grant/Research Support: Revance, Voyager Therapeutics; Consultant: AbbVie, Acorda Therapeutics, Adamas, Allergan, Amneal, Arcadia, Britannia, Kyowa Kirin, Lundbeck, Merz, Neurocrine Biosciences, Sunovion, Supernus, Teva, US WorldMeds; Speaker’s Bureau: Acorda Therapeutics, Adamas, Amneal, Arcadia, Kyowa Kirin, Lundbeck, Neurocrine Biosciences, Sunovion, Supernus, Teva, US WorldMeds.

Faculty

Rajesh Pahwa, MD
Laverne and Joyce Rider Professor of Neurology
Chief, Parkinson and Movement Disorder Division
Director, Parkinson’s Foundation Center of Excellence
University of Kansas Medical Center
Kansas City, KS

Disclosures: Grant/Research Support: Abbott, AbbVie, Addex, Biogen, Biohaven, Boston Scientific, EIP Pharma, Global Kinetics, Impax, Intec Pharma, Lilly, NeuroDerm, Neuraly, Parkinson’s Foundation, Pharma Two B, Prilenia, Roche, SIS, Sun Pharma, Sunovion, Theranexus, Theravance Biopharma, US WorldMeds, Voyager Therapeutics; Consultant: Abbott, AbbVie, Acadia, Acorda Therapeutics, Adamas, Amneal, Britannia, Cala Health, Global Kinetics, Impel NeuroPharma, Kyowa Kirin, Lundbeck, Mitsubishi, Neurocrine Biosciences, Orbis Biosciences, PhotoPharmics, Prilenia, Sunovion, Teva Neuroscience, US WorldMeds.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.